scispace - formally typeset
Open AccessJournal ArticleDOI

2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk

TLDR
Authors/Task Force Members (François Macha, Colin Baigentb,∗∗,2, Alberico L. Catapanoc), ESC Committee for Practice Guidelines (CPG) (Stephan Windeckeraa), ESC National Cardiac Societies (Djamaleddine Nibouchean, Parounak H. Patelcl)
About
This article is published in Atherosclerosis.The article was published on 2019-09-02 and is currently open access. It has received 2972 citations till now. The article focuses on the topics: Lipid modification & Very low-density lipoprotein.

read more

Citations
More filters
Journal ArticleDOI

HDL cholesterol concentrations and risk of atherosclerotic cardiovascular disease - Insights from randomized clinical trials and human genetics.

TL;DR: A review of HDL cholesterol increasing trials in case-control and prospective cohort studies is presented in this paper, showing that HDL cholesterol concentrations do not appear to be a viable future path to target therapeutically for prevention of ASCVD.
Journal ArticleDOI

Is HDL cholesterol protective in patients with type 2 diabetes? A retrospective population-based cohort study.

TL;DR: The hypothesis that HDL cholesterol levels are nonprotective in patients with type 2 diabetes mellitus is corroborated, and the U-shaped association between HDL-cholesterol levels and mortality associated with infectious diseases should be verified by further studies.
Journal ArticleDOI

Thrombolysis In Myocardial Infarction (TIMI) Study Group: JACC Focus Seminar 2/8.

TL;DR: The TIMI (Thrombolysis In Myocardial Infarction) Study Group (TIMI) as mentioned in this paper was created by the National Heart, Lung, and Blood Institute (NHLBI) to study the efficacy and safety of the treatment of acute myocardial infarction with an emerging therapy.
Journal ArticleDOI

ApoB-Specific CD4 + T Cells in Mouse and Human Atherosclerosis

TL;DR: In this paper, the authors highlight adaptive immune mechanisms in atherosclerosis with a focus on CD4+ T cells, introduce novel technologies to detect ApoB-specific CD4-specific T cells at the single cell level.
References
More filters
Journal ArticleDOI

Atherosclerosis — An Inflammatory Disease

TL;DR: Atherosclerosis is an inflammatory disease as discussed by the authors, and it is a major cause of death in the United States, Europe, and much of Asia, despite changes in lifestyle and use of new pharmacologic approaches to lower plasma cholesterol concentrations.
Journal ArticleDOI

2013 ESH/ESC Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).

Giuseppe Mancia, +89 more
TL;DR: In this article, a randomized controlled trial of Aliskiren in the Prevention of Major Cardiovascular Events in Elderly people was presented. But the authors did not discuss the effect of the combination therapy in patients living with systolic hypertension.
Journal Article

Atherosclerosis is an Inflammatory Disease

TL;DR: Despite changes in lifestyle and the use of new pharmacologic approaches to lower plasma cholesterol concentrations, cardiovascular disease continues to be the principal cause of death in the United States, Europe, and much of Asia.

Standards of Medical Care in Diabetes

TL;DR: These standards of care are intended to provide clinicians, patients, researchers, payors, and other interested individuals with the components of diabetes care, treatment goals, and tools to evaluate the quality of care.
Related Papers (5)

2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular riskThe Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS)

François Mach, +120 more